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Prolonged prone positioning 
under VV-ECMO is safe and improves 
oxygenation and respiratory compliance
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Abstract 
Background: Data are sparse regarding the effects of prolonged prone positioning (PP) during VV-ECMO. Previous 
studies, using short sessions (<12 h), failed to find any effects on respiratory system compliance. In the present analy-
sis, the effects of prolonged PP sessions (24 h) were retrospectively studied with regard to safety data, oxygenation 
and respiratory system compliance.
Methods: Retrospective review of 17 consecutive patients who required both VV-ECMO and prone positioning. PP 
under VV-ECMO was considered when the patient presented at least one unsuccessful ECMO weaning attempt after 
day 7 or refractory hypoxemia combined or not with persistent high plateau pressure. PP sessions had a duration of 
24 h with fixed ECMO and respiratory settings. PP was not performed in patients under vasopressor treatment and in 
cases of recent open chest cardiac surgery.
Results: Despite optimized protective mechanical ventilation and other adjuvant treatment (i.e. PP, inhaled nitric 
oxide, recruitment maneuvers), 44 patients received VV-ECMO during the study period for refractory acute respiratory 
distress syndrome. Global survival rate was 66 %. Among the latter, 17 patients underwent PP during VV-ECMO for a 
total of 27 sessions. After 24 h in prone position, PaO2/FiO2 ratio significantly increased from 111 (84–128) to 173 (120–
203) mmHg (p < 0.0001) while respiratory system compliance increased from 18 (12–36) to 32 (15–36) ml/cmH2O 
(p < 0.0001). Twenty-four hours after the return to supine position, tidal volume was increased from 3.0 (2.2–4.0) to 3.7 
(2.8–5.0) ml/kg (p < 0.005). PaO2/FiO2 ratio increased by over 20 % in 14/14 sessions for late sessions (≥7 days) and in 
7/13 sessions for early sessions (<7 days) (p = 0.01). Quantitative CT scan revealed a high percentage of non-aerated 
or poorly-aerated lung parenchyma [52 % (41–62)] in all patients. No correlation was found between CT scan data and 
respiratory parameter changes. Hemodynamics did not vary and side effects were rare (one membrane thrombosis 
and one drop in ECMO blood flow).
Conclusion: When used in combination with VV-ECMO, 24 h of prone positioning improves both oxygenation and 
respiratory system compliance. Moreover, our study confirms the absence of serious adverse events.
Keywords: ARDS, ECMO, Prone positioning
© 2015 Kimmoun et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
One year after the publication of the PROSEVA study, the 
association of prone positioning (PP) and lung-protective 
ventilation has become routine management for patients 
with acute respiratory distress syndrome (ARDS) [1]. 
However, refractory ARDS is still observed in all recent 
observational and randomized trials [1–3]. In these 
cases, veno-venous extra-corporeal membrane oxygena-
tion (VV-ECMO) is indicated while awaiting lung func-
tion recovery [4]. Indeed, in the CESAR trial, a protocol 
including VV-ECMO was associated with a decreased 
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mortality rate when compared to a conventional lung 
protective strategy [2].
The management of persistent severe hypoxemia 
under VV-ECMO requires a multi-step clinical approach 
including the optimization of VV-ECMO blood flow, red 
blood cell transfusion, moderate hypothermia, optimiza-
tion of native lung function, short-action beta-blockers 
and finally PP [5]. PP can be effective in patients with 
VV-ECMO given that the use of ultra-protective ventila-
tion [i.e. 3–4 mL/kg Vt] may increase the proportion of 
poorly-aerated areas in dependent lung regions [6]. As 
a result, PP during VV-ECMO may recruit the dorsal 
regions of the lungs, facilitate lung drainage and therefore 
improve oxygenation. The value of PP during VV-ECMO 
has furthermore been previously described in a few stud-
ies, the largest being a study by Guervilly et al. in which 
12  h of PP significantly improved the PaO2/FiO2 ratio 
in 15 ARDS patients on VV-ECMO after a median of 
9 days [7]. Altogether, data from this and other previously 
published studies suggest that PP during VV-ECMO is 
safe when performed by a referent team and ultimately 
improves oxygenation. Of note, these studies failed to 
find any improvement in respiratory system compliance 
[6–11].
Since PP during VV-ECMO also carries potentially 
harmful effects, it is thus imperative to better delineate 
its effects and putative indications.
Previous studies, using short sessions (>12  h), failed 
to find any effects on respiratory system compliance. In 
light of the above, the present study was aimed at retro-
spectively analyzing the effects of prolonged PP sessions 
(24 h) on safety data, oxygenation and respiratory system 
compliance.
Methods
The ECMO database of our 14-bed ICU was retrospec-
tively reviewed to identify patients who received PP dur-
ing VV-ECMO between January 2012 (first treatment in 
our ICU) and January 2014. The study protocol was eval-
uated by the local Ethics Committee (Comité de Réflex-
ion Ethique Nanceien Hospitalo-Universitaire) which 
waived written informed consent due to both the retro-
spective study design and because PP and VV-ECMO are 
an integral part of care provided to patients with ARDS. 
All patients or their relatives were informed that some 
data could be used for clinical research. We included 
patients with severe ARDS as defined by the BERLIN 
consensus [12].
ARDS management
All patients were treated in accordance with the lat-
est recommended guidelines. In particular, treatment in 
ICU included the systematic use of protective ventilation, 
transient use of paralyzing agents, diuresis to dry weight, 
prone positioning, recruitment maneuvers, transient use 
of inhaled nitric oxide and high positive end expiratory 
pressure (PEEP) levels [2].
Indication of ECMO
VV-ECMO was considered in patients with an optimal 
protective ventilator setting (Vt at 6 mL/kg of predicted 
body weight, PEEP adjusted to maintain a plateau pres-
sure (pPlat) between 27 and 30  cmH2O) after the fail-
ure of at least one prone positioning session with one of 
the following criteria adapted from the ongoing EOLIA 
trial: (1) PaO2/FiO2 < 50 mmHg for more than 3 h under 
FiO2  >  80  %; (2) PaO2/FiO2  <  85  mmHg for more than 
6 h; (3) pPlat > 35 cmH2O despite adjustment of Vt and 
PEEP; (4) pH < 7.25 for more than 6 h despite an increase 
in respiratory rate to 35/min. VV-ECMO was either initi-
ated in our intensive care unit (ICU) or in another hospi-
tal. In the latter instance, all patients were transferred to 
our ICU immediately after instituting VV-ECMO by our 
mobile ECMO team.
ECMO management
All VV-ECMOs were performed using percutane-
ous cannulation under echocardiography. A femoro-
jugular circuit was implanted whenever possible, with 
femoro–femoral jugular circuit as an alternative. A 
servo-controlled centrifugal pump (Rotaflow console, 
Maquet, Hirrlingen, Germany) and poly-methyl pen-
tene oxygenators (Quadrox Bioline oxygenator system 
Maquet, Hirrlingen, Germany) were used. The circuit 
and the oxygenator were fully coated with heparin. 
VV-ECMO flow was adapted daily according to car-
diac output measured by echocardiography in order to 
maintain an ECMO blood flow/cardiac output ratio of 
at least 0.7 [13]. Sweep gas flow was titrated in order 
to maintain PaCO2 between 40 and 45  mmHg. Oxy-
gen fraction delivered on the membrane (FDO2) was 
adjusted on post-oxygenator blood gas. Heparin was 
continuously infused to obtain an anti-Xa activity at 
0.1–0.2.
Respiratory management under VV‑ECMO
All patients were ventilated in volume control mode. 
Ultraprotective ventilation was applied during the first 
48  h with the following settings: Vt at 1.5–3  ml/kg of 
predicted body weight, respiratory rate between 8 and 
12/min, PEEP between 10 and 18 adapted for a pPlat at 
25 cmH2O. FiO2 was adapted for a SpO2 between 88 and 
95 %. All patients were sedated and paralyzed by besilate 
cisatracurium (Hospira France, France) during the first 
24 h. After 24 h, besilate cisatracurium was discontinued 
when possible.
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Weaning procedure
After the first 48  h, Vt was increased daily when pos-
sible, respecting a pPlat at 25  cmH2O. When Vt was 
>5  ml/kg of predicted body weight and respiratory rate 
>15/min, ECMO and sweep gas flow were progressively 
decreased respecting the following criteria: (1) PaO2/
FIO2  >  150  mmHg, (2) FiO2 on ventilator <60  %, (3) 
PaCO2 < 50 mmHg, (4) pPlat < 25 cmH2O. ECMO was 
halted if the above criteria were respected in a non par-
alyzed patient after a successful 12–24  h session with a 
sweep gas flow at 0 L/min.
Indication for prone positioning under VV‑ECMO
Prone positioning placement was only performed in one 
of the two following conditions: (1) Failure of attempts to 
wean VV-ECMO after at least 7 days under VV-ECMO 
combined with the need of therapeutic sedation, (2) 
Refractory hypoxemia with PaO2/FiO2 ratio <85  mmHg 
under FiO2 100 % both on the ventilator and the mem-
brane despite optimal VV-ECMO and ventilator settings 
combined or not with persistent high plateau pressure 
(>25  cmH2O) despite ultra-protective ventilation. Fur-
ther sessions were also performed according to the same 
indications.
Contraindication for placement in prone position 
under VV‑ECMO
Given the potential risks of PP during VV-ECMO, PP 
was not performed in patients under vasopressor treat-
ment and in cases of recent open chest cardiac surgery. 
PP was proposed only in patients who were still under 
sedation and in whom it was not possible to use partial 
ventilatory support.
Protocol for prone positioning under VV‑ECMO (Additional 
files 1, 2)
The protocol was adapted from PROSEVA guidelines 
for prone positioning placement and has been published 
elsewhere [1, 6]. The detailed protocol is described in the 
supplementary material.
Study parameters
The use of PP in our ICU with or without ECMO is 
described in an institutional procedure. For all sessions, 
parameters were recorded at three time intervals: prior to 
prone positioning placement, after 24 h in prone position 
and 24 h after the return to supine position. As specified 
in the procedure, in order to formally objectify respira-
tory improvement, respiratory and VV-ECMO param-
eters were maintained constant throughout the entire 
prone positioning session. An increase in FiO2 and/or 
VV-ECMO blood flow was only considered when SpO2 
was below 85 %. VV-ECMO and ventilator settings were 
adjusted according to lung recovery after the prone posi-
tioning session. Data analysis also included the record-
ing, at the above three pre-specified times, of complete 
blood gas (PaO2, PaCO2, pH, HCO3−, SaO2), respira-
tory parameters (respiratory rate, Vt, PEEP, FiO2, pPlat, 
respiratory system compliance) and VV-ECMO param-
eters (blood flow, sweep gas flow, oxygen delivery by VV-
ECMO device: FDO2). Respiratory system compliance 
(RS compliance) was computed by dividing tidal volume 
by pPlat (measured during an end-inspiratory pause (1 s) 
minus total PEEP. Total PEEP was measured by using an 
expiratory pause (5  s). Driving pressure was calculated 
as plateau pressure minus PEEP [14]. The pre-ECMO 
survival probability was also calculated according to the 
RESP score [15].
Chest CT analysis
In patients who underwent a computed tomography 
(CT) scan within the 3 days prior to placement in prone 
position, a measurement of the amount of non-aerated 
lung tissue was performed according to an adapted pre-
viously-published method by Malbouisson et al. [16]. The 
detailed protocol is presented in the Additional file 3 (see 
Figure S1) [17].
Adverse effects
Three categories were systematically reported in the pro-
cedure: (1) adverse effects related to the cannulas and 
VV-ECMO device during the prone position session 
(drop in flow necessitating fluid resuscitation, oxygenator 
thrombosis, cannula removal, bleeding from cannulation 
sites), (2) adverse effects related to the tracheal tube and 
the ventilator device (accidental tracheal extubation, tube 
displacement) and (3) adverse effects related to the other 
catheters (accidental wrenching of central venous or arte-
rial lines and nasogastric tube).
Statistical analysis
All analyses were performed using SAS software R9.3 
(SAS Institute, Cary, NC, USA). The two-tailed signifi-
cance level was set at p  <  0.05. Results are respectively 
presented as median (1st–3rd quartiles) and frequency 
(percentage) for continuous and discrete variables. The 
paired Wilcoxon test and Fisher’s exact test were car-
ried out for intra-group (before-after PP) and inter-group 
(respiratory response) comparisons, respectively. Since 
11 intra-group comparisons were performed on the same 
subjects at the end of each session and 24  h thereafter, 
significance levels were adjusted for multiple testing at 
each respective time points. Results were analyzed for the 
first session (n = 17) as well as for all sessions (n = 27), 
considering that the increase in gas exchange of a given 
PP session does not predict survival [18]. Moreover, the 
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Despite optimized protective mechanical ventilation and 
other adjuvant treatment (i.e. PP, inhaled nitric oxide, 
recruitment maneuvers), 44 patients received VV-ECMO 
during the study period for refractory acute respiratory 
distress syndrome. Global survival rate was 66 %. Among 
the latter, 17 patients underwent PP during VV-ECMO. 
Pre-ECMO survival probability according to the RESP 
score was 76 % (33–90). All of the patients had a severe 
ARDS according to the Berlin definition [19]. Before 
being placed on VV-ECMO, 13/17 (76 %) patients were 
prone positioned. Prior to ECMO implantation, 4/14 
patients previously responded to PP in terms of oxygena-
tion but developed major respiratory acidosis and high 
plateau pressure. Femoro–jugular VV-ECMO was used 
in 16/17 patients and femoro-femoral VV-ECMO in one 
patient. ARDS was related to an infectious process in all 
cases. Four patients presented an influenza infection at 
admission.
Prone positioning was considered after a median delay 
of 6 days of VV-ECMO (4–12). Sixteen of 27 prone posi-
tion sessions were performed after this median period. 
Indications for PP included unsuccessful VV-ECMO 
weaning attempts after at least 7 days under VV-ECMO 
in 11/17 patients and refractory hypoxemia with PaO2/
FiO2 ratio <85  mmHg despite optimal VV-ECMO and 
ventilator settings in 6/17 patients. For three patients 
(6 sessions), refractory hypoxemia was associated with 
elevated plateau pressure despite ultra-protective ventila-
tion. Four patients had 3 sessions and two patients had 
2 sessions. The median delay between each session was 
2 days (1–4).
Effects of prone position session on respiratory state
Pre-PP parameters are described in Table  2. Twenty-
seven sessions were performed. All sessions had an identi-
cal duration of 24 h. In 23/27 sessions, nurses described 
a major increase in sputum drainage. After 24  h in PP 
under the same respiratory and ECMO settings, PaO2/
FiO2 increased from 111 (84–128) to 173 (120–203) 
mmHg (p < 0.0001) (Fig. 1). PaO2/FiO2 increased by more 
than 20 % in 22/27 sessions. According to this threshold 
value, when PP was performed after day 7, PaO2/FiO2 
ratio increased by more than 20 % in 14/14 sessions. Con-
versely, only 7/12 sessions had a higher than 20 % increase 
in PaO2/FiO2 ratio before day 7 (p = 0.01). RS compliance 
significantly increased after 24 h in PP from 18 (12–36) to 
32 (15–36) ml/cmH2O (p < 0.005) (Fig. 2). Additional file 
4: Figure S2 and Additional file 5: Figure S3 (see supple-
mental digital content) provide individual data for plateau 
pressure and RS compliance, respectively. Twenty-four 
Table 1 Baseline characteristics
SAPS II simplified acute physiology score II, SOFA sequential organ failure 
assessment, ARDS acute respiratory distress syndrome, ECMO extracorporeal 
membrane oxygenation, ICU intensive care unit
Median (quartiles) or 
n (%), n = 17
Age (years) 45 (36–55)
Male gender 12/17 (71 %)
Body mass index (kg/m2) 27 (23–34)
SAPS II score 44 (38–59)
SOFA score (at ICU admission) 12 (8–15)
SOFA score (before first PP session) 7 (5–11)
Pre-existing conditions
 Congestive heart failure 2/17 (12 %)
 Neoplasia 0/17
 Chronic respiratory disorders 1/17 (6 %)
 Neuropsychiatric disorders 4/17 (24 %)
 None 10/17 (59 %)
Causes of ARDS
 Gram-negative pneumonia 7/17 (41 %)
 Gram-positive pneumonia 8/17 (47 %)
 Influenza virus 4/17 (24 %)
 Abdominal septic shock 2/17 (12 %)
 Sarcoidosis 1/17 (6 %)
Prone positioning before ECMO 13/17 (76 %)
Pre-ECMO survival probability (%) (RESP score) 76 (33–90)
Duration of hospitalization before ICU (days) 1 (1–2)
Duration under ECMO (days) 18 (13–26)
Duration of ICU stay (days) 54 (36–66)
Survival at discharge 16/17 (94 %)
Table 2 Baseline characteristics
PaO2, PaO2 arterial oxygen pressure, PaCO2 partial pressure of carbon dioxide 
in arterial blood, FiO2 fraction of expired oxygen, PEEP positive end expiratory 
pressure, RS compliance respiratory system compliance, ECMO extracorporeal 
membrane oxygenation
PaO2/FiO2 (mmHg) 111 (84–128)
PaCO2 (mmHg) 42 (39–43)
Tidal volume (ml/kg) 3.0 (2.2–4.0)
Arterial pH 7.42 (7.39–7.44)
PEEP (cmH2O) 12 (6–13)
Plateau pressure (cmH2O) 24 (22–25)
RS compliance (ml/cmH2O) 18 (12–36)
Respiratory frequency (cycles/min) 17 (10–25)
ECMO settings
 FiO2 (%) 70 (70–90)
 ECMO blood flow (l/min) 4.7 (3.7–5.5)
 Sweep gas (l/min) 5.0 (3.0–5.0)
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hours after the return to supine position, tidal volume 
was significantly increased from 3 (2.2–4) before PP to 3.7 
(2.8–5) ml/kg of predicted body weight (p < 0.05). Arterial 
PCO2 did not change during and after PP.
Correlation between lung condensation and PaO2/FiO2 
response
Fifteen CT scans were performed prior to placement in 
prone position. All patients exhibited a high percent-
age of non-aerated or poorly-aerated lung parenchyma 
prior to PP: 52 % (41–62). Thus, no correlation was found 
between the increase in PaO2/FiO2 ratio and the amount 
of non-aerated lung tissue measured on chest scans 
(r = 0.064, p = 0.82).
Adverse events attributable to PP
In one patient, an oxygenator thrombosis occurred while 
one other patient required fluid resuscitation in order to 
correct a drop in VV-ECMO flow.
No adverse event was related to either the tracheal 
tube, the ventilator device or other catheters.
Discussion
The main findings of the present study are that (1) in a 
majority of patients, PP markedly improved oxygena-
tion during VV-ECMO and was not associated with 
side effects confirming the Guervilly et al. study, (2) the 
improvement in oxygenation appeared to be more effi-
cient when applied after 7  days of VV-ECMO, (3) con-
trary to the Guervilly et al. study, PP was associated with 
an improvement in lung compliance therefore allowing 
the use of increased Vt and (4) there was no correlation 
between the volume of condensation and PP efficiency.
Prone positioning during VV‑ECMO improves oxygenation
All currently published studies are consistent with 
regard to the effect of PP on oxygenation during VV-
ECMO. Clearly, PP improves oxygenation in a majority 
of patients. Moreover, previous studies mainly studied 
the effects of PP when performed late after VV-ECMO 
initiation (8 days in the Guervilly et al. study). It appears 
that for some patients PP was effective under ECMO 
and ineffective prior to ECMO. It is likely that time is an 
important factor in allowing lung healing and sympto-
matic treatments such as antibiotics to be effective. The 
decrease in lung aggression secondary to ultraprotective 
ventilation should also be considered.
Prone positioning during VV‑ECMO improves respiratory 
system compliance and allows increased tidal volume
Importantly, PP was associated with a marked decrease 
in plateau pressure in patients in whom it was not pos-
sible to maintain this pressure under 25  cmH2O. In 
randomized controlled trials comparing supine and 
prone positions, the results on respiratory compliance 
have been inconsistent. Indeed, Mancebo et  al. noted 
higher compliance of the respiratory system in the prone 
Fig. 1 Effect of prone positioning on PaO2/FiO2 ratio before and 
after 24 h of prone position as well as 24 h after the return to supine 
position; *p < 0.05
Fig. 2 Effect of prone positioning on respiratory system compliance 
before and after 24 h of prone position as well as 24 h after the return 
to supine position; *p < 0.05
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position, whereas Guerin et al. and Taccone et al. did not 
[20, 21]. Previous studies using PP during VV-ECMO also 
failed to demonstrate any significant changes in static 
compliance. Guervilly et al. suggested that the improve-
ment in oxygenation without concomitant increase in 
respiratory static compliance and without decrease in 
PaCO2 at constant levels of minute ventilation and sweep 
gas flow do not suggest lung recruitment by PP with 
relatively small Vt and high levels of PEEP but rather an 
improvement in VA/Q mismatch. Unfortunately, no CT 
scan data were provided in their study. Herein, all of our 
patients had major posterior condensation (>50  % of 
lung volume) and thus it is likely that PP in this situation 
allows lung recruitment. Arguing in favor of this hypoth-
esis is the fact that PP further allows the use of increased 
Vt. Importantly, in 23/27 sessions, nurses described a 
major increase in sputum drainage that may have con-
tributed to recruitment. Another hypothesis to explain 
this discrepancy is that prolonged PP sessions were used 
in our study (24 h as opposed to 12 h), which may have 
contributed to the observed improvement in compliance. 
Finally, the discrepancy could be due to different patient 
populations, i.e. patients still under sedation in whom it 
was not possible to use partial mode of ventilatory sup-
port or to a different phase of the disease comparatively 
to previous reports.
The driving pressure (plateau pressure minus PEEP) is 
associated with ARDS prognosis, [14] but also with treat-
ment efficiency when associated with decreases in ΔP. 
Interestingly, the driving pressure observed in our study 
was relatively low and the use of PP was associated with a 
further decrease in driving pressure.
Study limitations
Although the present constitutes the largest study rela-
tive to the use of PP during VV-ECMO, the number of 
studied patients remains relatively small. Nevertheless, 
severe ARDS treated with ECMO and needing prone 
positioning is a rare occurrence and thus it is unlikely 
that a multicenter randomized study will be performed. 
Accordingly, only 36 cases have been previously reported 
in the literature in which session durations differed con-
siderably. Therefore, we firmly believe that this study 
adds valuable information, first in confirming previous 
but scarce data but also in extending these data with new 
findings, notably on compliance.
The small sample size may also have had a bearing on 
our findings regarding the comparison between early 
and late sessions. In addition, specific predefined criteria 
were chosen as to whether or not to use PP in our VV-
ECMO patients. Therefore, our results and conclusions 
are only valuable when considering the present clinical 
algorithm. Finally, because of the retrospective nature of 
the present study, it was not possible to study the mecha-
nism involved in PP effects during VV-ECMO.
Conclusions
When used in combination with VV-ECMO, 24  h of 
prone positioning improves both oxygenation and res-
piratory system compliance. Moreover, our study con-
firms the absence of serious adverse events. Currently, 
it remains unknown when and for which indication 
prone positioning should be systematically applied dur-
ing VV-ECMO. Therefore, further studies are needed 
to better delineate prone positioning indications during 
VV-ECMO.
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Additional file 5: Figure S3. Evolution of respiratory system compliance 
before and 24 h after prone positioning. Individual data.
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